Investors Asset Management of Georgia’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,400
Closed -$383K 171
2022
Q4
$383K Sell
2,400
-1,300
-35% -$206K 0.2% 112
2022
Q3
$521K Hold
3,700
0.27% 88
2022
Q2
$539K Hold
3,700
0.28% 84
2022
Q1
$600K Hold
3,700
0.3% 89
2021
Q4
$701K Hold
3,700
0.33% 77
2021
Q3
$748K Hold
3,700
0.39% 68
2021
Q2
$746K Hold
3,700
0.4% 67
2021
Q1
$649K Hold
3,700
0.38% 69
2020
Q4
$628K Hold
3,700
0.42% 59
2020
Q3
$600K Hold
3,700
0.4% 55
2020
Q2
$603K Hold
3,700
0.42% 53
2020
Q1
$474K Hold
3,700
0.39% 57
2019
Q4
$516K Hold
3,700
0.31% 74
2019
Q3
$437K Hold
3,700
0.28% 85
2019
Q2
$477K Hold
3,700
0.32% 76
2019
Q1
$475K Hold
3,700
0.33% 73
2018
Q4
$410K Hold
3,700
0.34% 76
2018
Q3
$503K Hold
3,700
0.35% 72
2018
Q2
$444K Hold
3,700
0.33% 78
2018
Q1
$445K Hold
3,700
0.33% 73
2017
Q4
$461K Hold
3,700
0.33% 75
2017
Q3
$496K Hold
3,700
0.37% 67
2017
Q2
$465K Hold
3,700
0.32% 72
2017
Q1
$440K Hold
3,700
0.31% 73
2016
Q4
$398K Hold
3,700
0.29% 81
2016
Q3
$426K Hold
3,700
0.32% 68
2016
Q2
$379K Hold
3,700
0.29% 78
2016
Q1
$384K Hold
3,700
0.32% 74
2015
Q4
$470K Hold
3,700
0.39% 55
2015
Q3
$423K Hold
3,700
0.38% 60
2015
Q2
$499K Hold
3,700
0.43% 56
2015
Q1
$479K Hold
3,700
0.39% 64
2014
Q4
$427K Buy
+3,700
New +$417K 0.37% 65

Other funds holding BBH

Investors Asset Management of Georgia's BBH Position: Q1 2023 in Review

Investors Asset Management of Georgia sold out of VanEck Biotech ETF (BBH) in Q1 2023, closing a stake of 2,400 shares — an estimated $383K sold.

Investors Asset Management of Georgia first reported a position in BBH in Q4 2014 and held it in 33 quarters. The position peaked at $748K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2023.

  • Investors Asset Management of Georgia reported no remaining VanEck Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 2,400 VanEck Biotech ETF shares in Q1 2023, an estimated $383K.
  • Investors Asset Management of Georgia first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 33 quarters.
  • Investors Asset Management of Georgia's VanEck Biotech ETF position peaked at $748K in Q3 2021.
  • 115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2023.

Based on Investors Asset Management of Georgia's 13F filing for Q1 2023, filed 1 May 2023.